about
Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the futureSwitching treatments in haemophilia: is there a risk of inhibitor development?Disease-specific quality-of-life measurement tools for haemophilia patients.Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.Beyond patient benefit: clinical development in hemophilia.Development of a new instrument for the assessment of psychological predictors of well-being and quality of life in people with HIV or AIDS.Development and psychometric testing of the Hemophilia Well-being Index.Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.Joint disease, the hallmark of haemophilia: what issues and challenges remain despite the development of effective therapies?The role of depression, anxiety, stress and adherence to treatment in dialysis patients health-related quality of life: a systematic review of the literature.Rationale for individualizing haemophilia care.Psychometric field testing of the HemoLatin-QoL questionnaire.Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.Field Psychometric Testing of the Instrument for Assessment of Psychological Predictors of Well-Being and Quality of Life in People with HIV or AIDS.A Spanish Study on Psychological Predictors of Quality of Life in People with HIV.Tailoring care to haemophilia patients' needs: which specialty and when?Predictors of treatment difficulties and satisfaction with haemophilia therapy in adult patients.Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia.Psychometric field study of the new haemophilia quality of life questionnaire for adults: the 'Hemofilia-QoL'.Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis.Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease.The short-term impact of peers as co-facilitators of an HIV prevention programme for adolescents: a cluster randomised controlled trial.Perceived stress is associated with CD4+ cell decline in men and women living with HIV/AIDS in SpainAdherence to ARV medication in Romanian young adults: Self-reported behaviour and psychological barriersImpact of an interdisciplinary training course on counselling and decision making support for nephrology department professionalsEditorial to 30th anniversary: historical links between the Psicologia: Reflexão e Crítica and the postgraduate psychology program at Universidade Federal do Rio Grande do Sul (Brazil)Health-related quality of life of people living with HIV infection in Spain: a gender perspectiveDevelopment of an inventory to assess perceived barriers related to PKU treatment
P50
Q26853631-99D5A954-4C03-4F73-AE5D-68065E19FC21Q27001016-005A4919-797C-439F-9EC2-F58D53B2BB53Q35915643-B7E02329-CF1F-41CA-B999-AD12F13740E0Q36740003-04F7BB25-69BF-4606-AEFA-FEC9DF602E94Q37977140-99D9EE95-9CBC-4A41-BD78-B810449E1FE7Q38006844-75216204-D5C1-493A-9153-4DC6122E4DBFQ38018282-9C4DB841-6533-47F5-B81C-B95DCDE1BEB3Q38040655-D4E53FAB-209E-45C7-8D87-6AF4CB6A2515Q38079624-151F303C-AD2E-4ECA-8205-40D94DC96F38Q38194778-EF2E81E8-2B72-497E-A6D5-6FE1B8AD58E4Q38254642-8C4A2508-1EBE-47F7-A291-D7169F6E60DCQ38268161-BB240D73-E2F1-415E-8DB3-E670F98501A3Q39535630-36008799-077E-4AFB-86EE-36D6DA76D508Q39927203-D085F5A0-B402-4F5B-A2F3-8EF8C66AF5DFQ40301707-67CE2D3C-68FD-44F4-8924-964E2522C058Q40976283-1B9BDAA2-C205-42A1-87BC-1A8A6C36A0CDQ43198121-77C7DF9D-44CF-4086-8EC3-9AC7957AD58EQ45870701-81FA1E14-38E8-4C81-9D15-2743BA4EB467Q45876370-13594683-522E-4238-B6E7-2A281AA46FA6Q45887799-DBA147FA-346C-474E-B84B-18E402D606E6Q46767600-851E46B0-307A-49DA-8AE4-E9393533DCE5Q47951672-19D9B451-6292-47BD-8C97-7A021A335FA3Q50673104-08F70F9F-3231-47DB-A69B-BF5BB12466F3Q58301438-71C538D2-D967-48AF-A977-1193B38AC5D9Q62014616-93CDC878-FC41-4EB4-A95F-453B67D11AE9Q84238043-B3E9D9C2-6EA7-4C4B-BF29-113739EB2E00Q89564588-3CB23005-2026-46D5-8723-43F99D64ED39Q92655535-AEB0201C-C17D-45B8-96AF-31DE6346D438Q94484601-ABE930A8-8429-4679-84BF-4F8026AC15BE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
E Remor
@ast
E Remor
@en
E Remor
@es
E Remor
@nl
E Remor
@sl
type
label
E Remor
@ast
E Remor
@en
E Remor
@es
E Remor
@nl
E Remor
@sl
prefLabel
E Remor
@ast
E Remor
@en
E Remor
@es
E Remor
@nl
E Remor
@sl
P106
P1153
6602186430
P31
P496
0000-0002-5393-8700